Skip to main content
. 2023 May 15;24(10):8789. doi: 10.3390/ijms24108789

Figure 8.

Figure 8

2D and 3D interactions of (A) GRL0617 (as a standard SARS-CoV-2 PLpro inhibitor) and (B) CHA-37 in the active site of the SARS-CoV-2 PLpro enzyme.